Skip to main content
    R

    Rezolute Inc (RZLT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.58
    -0.08 (-2.05%)

    Market Cap: $353.54M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Rezolute Inc (RZLT) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Rezolute are Zevra Therapeutics (ZVRA), Rocket Pharmaceuticals (RCKT) and Regenxbio (RGNX). By market cap, Rezolute ranks 10th of the 13 companies on this page; Zevra Therapeutics (ZVRA) is the largest at $540.30M.

    Peer Comparison

    RZLT's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Rezolute (RZLT)$353.54MN/AN/A0.0%N/A0.0%0.00%
    Zevra Therapeutics Inc. (ZVRA)$540.30M11.6x3.7x52.8%N/A44.9%0.00%
    Rocket Pharmaceuticals Inc (RCKT)$256.82MN/AN/A0.0%-2.3%0.0%0.00%
    Regenxbio Inc (RGNX)$505.18MN/A3.1x-113.9%N/A-69.2%0.00%
    PepGen Ltd (PEPG)$410.98MN/AN/A0.0%N/A0.0%0.00%
    Fulcrum Therapeutics Inc (FULC)$287.96MN/AN/A0.0%N/A-100.0%0.00%
    Avalo Therapeutics Inc (AVTX)$448.71MN/AN/A0.0%N/A-69.3%0.00%
    Contineum Therapeutics, Inc. Class A Common Stock (CTNM)$387.16MN/AN/A0.0%N/A0.0%0.00%
    CorMedix Inc (CRMD)$370.64M6.3x0.9x15.5%13.9%-47.7%0.00%
    Gyre Therapeutics Inc. (GYRE)$471.74MN/A3.8x-22.7%N/A0.7%0.00%
    Larimar Therapeutics Inc (LRMR)$313.73MN/AN/A0.0%N/A0.0%0.00%
    Prothena Corporation plc (PRTA)$419.01MN/A7.8x-45.4%N/A-74.3%0.00%
    ARS Pharmaceuticals, Inc (SPRY)$391.06MN/A2.9x-163.6%-143.8%16.0%0.00%
    Peer median$401.02M9.0x3.4x0.0%-2.3%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Rezolute, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Zevra Therapeutics Inc. (ZVRA)
    Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions...
    ZVRA competitors
    Rocket Pharmaceuticals Inc (RCKT)
    Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases.
    RCKT competitors
    Regenxbio Inc (RGNX)
    REGENXBIO Inc., a clinical-stage biotechnology company, offers candidate gene therapy products to deliver genes to cells to address genetic defects or to enable...
    RGNX competitors
    PepGen Ltd (PEPG)
    PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious...
    PEPG competitors
    Fulcrum Therapeutics Inc (FULC)
    Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products to improve the lives of patients with genetically defined...
    FULC competitors
    Avalo Therapeutics Inc (AVTX)
    Avalo Therapeutics Inc is a forward-thinking clinical-stage biotechnology company focused on developing transformative therapies for rare and underserved...
    AVTX competitors
    Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
    Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies...
    CTNM competitors
    CorMedix Inc (CRMD)
    CorMedix Inc., a biopharmaceutical company, focuses on developing and marketing therapeutic products for the prevention and treatment of infectious...
    CRMD competitors
    Gyre Therapeutics Inc. (GYRE)
    Gyre Therapeutics Inc. is a pioneering biopharmaceutical company at the forefront of developing advanced therapies for rare and complex diseases.
    GYRE competitors
    Larimar Therapeutics Inc (LRMR)
    Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases.
    LRMR competitors
    Prothena Corporation plc (PRTA)
    Prothena Corporation plc, an advanced stage clinical company, is focused on the discovery and development of new therapies for life-threatening diseases...
    PRTA competitors
    ARS Pharmaceuticals, Inc (SPRY)
    ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine aerosol with absorption technology for patients and their families at risk of severe...
    SPRY competitors

    Frequently Asked Questions About RZLT

    Who are Rezolute's main competitors?

    The companies most similar to Rezolute include Zevra Therapeutics (ZVRA), Rocket Pharmaceuticals (RCKT), Regenxbio (RGNX), PepGen (PEPG) and Fulcrum Therapeutics (FULC), listed from the closest match.

    Who is Rezolute's biggest competitor?

    Zevra Therapeutics (ZVRA) is both the largest of the similar companies at $540.30M and the closest match by business profile, size, sector and industry.

    How does RZLT stock compare with its competitors?

    RZLT's net margin is 0.0% against a peer median of 0.0%.

    Which of Rezolute's competitors pays a higher dividend?

    Rezolute pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Rezolute bigger than its competitors?

    No. Rezolute is 10th by market cap among the 13 companies on this page; the largest is Zevra Therapeutics (ZVRA) at $540.30M.